A recent study of biomarkers of inflammation in ALS patients and healthy controls revealed an increased plasma TNF‐α level in C9-ALS patients in comparison with non-C9-ALS patients and controls, suggesting a pronounced role of inflammation in C9-ALS [237]. The gene discussed is C9; the disease is amyotrophic lateral sclerosis.